Filing Details

Accession Number:
0001086377-13-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-15 17:21:25
Reporting Period:
2013-03-14
Filing Date:
2013-03-15
Accepted Time:
2013-03-15 17:21:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1168220 Uluru Inc. ULUR Pharmaceutical Preparations (2834) 412118656
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1086377 P Kerry Gray C/O Uluru Inc.
4452 Beltway Drive
Addison TX 75001
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-14 1,000,000 $0.40 1,256,893 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Acquisiton 2013-03-14 600,000 $0.60 600,000 $0.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
600,000 2013-09-10 2018-03-14 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 100,000 Indirect By Kerry P. Gray, Trustee for the benefit of Michael J. Gray and Lindsay K. Gray
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Warrant $1.08 2011-07-28 2016-07-28 34,722 34,722 Direct
Common Stock Convertible Promissory Note $1.08 2011-07-28 2014-07-28 115,741 115,741 Direct
Common Stock Warrant $1.20 2011-06-13 2016-06-13 35,000 35,000 Direct
Common Stock Convertible Promissory Note $1.20 2011-06-13 2014-06-13 116,667 116,667 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2016-07-28 34,722 34,722 Direct
2014-07-28 115,741 115,741 Direct
2016-06-13 35,000 35,000 Direct
2014-06-13 116,667 116,667 Direct
Footnotes
  1. On March 14, 2013, Mr. Gray purchased from the Company 1,000,000 shares of common stock at a price of $0.40 per share. The purchase will take place at the following four closings over the next twelve months: (i) 200,000 shares of common stock will be purchased at a price of $80,000 at the initial closing on March 14, 2013, (ii) 250,000 shares of common stock will be purchased at a price of $100,000 on July 14, 2013, (iii) 300,000 shares of common stock will be purchased at a price of $120,000 on November 14, 2013, and (iv) 250,000 shares of common stock will be purchased at a price of $100,000 on March 14, 2014. In connection with his purchase of the Company's common stock, Mr. Gray was also issued a warrant to acquire up to 600,000 shares of the Company's common stock at a fixed exercise price of $0.60 per share. The warrant will become excercisable on September 10, 2013 subject to payment of the sums described above and has an expiration date of March 14, 2018.
  2. Includes 50,000 shares of common stock held by Kerry P. Gray, Trustee for the benefit of Michael J. Gray and 50,000 shares of common stock held by Kerry P. Gray, Trustee for the benefit of Lindsay K. Gray. Mr. Gray disclaims beneficial ownership of such shares of common stock.
  3. On July 28, 2011, Mr. Gray purchased from the Company a convertible promissory note in the principal amount of $125,000. The principal amount of the convertible promissory note is convertible into shares of the Company's common stock at a price of $1.08 per share. In connection with his purchase of the convertible promissory note, Mr. Gray was also issued a warrant to acquire up to 34,722 shares of the Company's common stock at a fixed exercise price of $1.08 per share with an expiration date of July 28, 2016.
  4. On June 13, 2011, Mr. Gray purchased from the Company a convertible promissory note in the principal amount of $140,000. The principal amount of the convertible promissory note is convertible into shares of the Company's common stock at a price of $1.20 per share. In connection with his purchase of the convertible promissory note, Mr. Gray was also issued a warrant to acquire up to 35,000 shares of the Company's common stock at a fixed exercise price of $1.20 per share with an expiration date of June 13, 2016.